Do regulators have a disincentive to approve medical devices?
AR is a key driver for operational and maintenance efficiency, as well as productivity.
FDA prioritizes an A-list and B-list for the guidance documents it plans to publish in FY 2017.
Device manufacturers need to identify, monitor and address cybersecurity vulnerabilities as part of postmarket device management.
Transformational technology is delivering effective and efficient training with precision.
A new technology from Nanomix is targeting fast detection to expedite patient treatment and improve outcomes.
Don’t skimp on conducting due diligence.
Several provisions are aimed at accelerating device innovation and access to medical products.
As the Internet of Things and the reimbursement environment transform the healthcare ecosystem, device manufacturers must position themselves to adapt.
The search for better ways to stop bleeding may benefit from international partnerships.